Fused thiazole derivatives as kinase inhibitors
    5.
    发明授权
    Fused thiazole derivatives as kinase inhibitors 失效
    融合噻唑衍生物作为激酶抑制剂

    公开(公告)号:US08093238B2

    公开(公告)日:2012-01-10

    申请号:US12445056

    申请日:2007-10-10

    摘要: A series of 5,5-dimethyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one and 7,7-dimethyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[5,4-c]azepin-4-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted benzofused morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. Formula (I).

    摘要翻译: 一系列5,5-二甲基-5,6-二氢-1,3-苯并噻唑-7(4H) - 酮和7,7-二甲基-5,6,7,8-四氢-4H- [1,3 ]噻唑并[5,4-c]氮杂-4-酮衍生物及其类似物,其在2-位被任选取代的苯并稠合的吗啉-4-基部分取代,作为PI3激酶的选择性抑制剂,因此 在医学上有益,例如在治疗炎症,自身免疫,心血管,神经变性,代谢,肿瘤,伤害感受或眼科疾病中。 式(I)。